1. Home
  2. PODD vs BRKR Comparison

PODD vs BRKR Comparison

Compare PODD & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$163.72

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Logo Bruker Corporation

BRKR

Bruker Corporation

HOLD

Current Price

$60.35

Market Cap

9.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PODD
BRKR
Founded
2000
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
9.0B
IPO Year
2007
2000

Fundamental Metrics

Financial Performance
Metric
PODD
BRKR
Price
$163.72
$60.35
Analyst Decision
Buy
Buy
Analyst Count
21
13
Target Price
$341.48
$48.54
AVG Volume (30 Days)
1.4M
2.0M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
0.58%
EPS Growth
N/A
N/A
EPS
1.30
0.02
Revenue
$2,708,100,000.00
$1,895,600,000.00
Revenue This Year
$24.55
$6.30
Revenue Next Year
$19.18
$3.81
P/E Ratio
$128.75
$2,821.00
Revenue Growth
30.73
N/A
52 Week Low
$138.79
$28.53
52 Week High
$354.88
$64.95

Technical Indicators

Market Signals
Indicator
PODD
BRKR
Relative Strength Index (RSI) 55.59 53.92
Support Level $141.67 $54.42
Resistance Level $164.59 $63.79
Average True Range (ATR) 6.04 3.19
MACD 0.83 -0.47
Stochastic Oscillator 62.33 51.63

Price Performance

Historical Comparison
PODD
BRKR

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: